C22H21N7O
Neat
399.46
1420478-90-5; (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide; Benzamide, 4-[8-amino-3-(2S)-2-pyrrolidinylimidazo[1, 5-a]pyrazin-1-yl]-N-2-pyridinyl-; MFCD32205328; (S)-4-(8-Amino-3-pyrrolidin-2-yl-imidazo[1, 5-a]pyrazin-1-yl)-N-pyridin-2-yl-benzamide; Axitinib Impurity N1; L7Y5ZXY8SP; SCHEMBL14636907; SCHEMBL29377106; C22H21N7O; RWBYECCAYSUTDK-INIZCTEOSA-N; SY464232; F90188; (S)-4-[8-Amino-3-(pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl]-N-(2-pyridyl)benzamide; 4-[8-amino-3-[(2S)-pyrrolidin-2-yl]imidazo[1, 5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide; 4-[8-azanyl-3-[(2S)-pyrrolidin-2-yl]imidazo[1, 5-a]pyrazin-1-yl]-N-pyridin-2-yl-benzamide; 4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1, 5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide and (S)-
4-[8-amino-3-[(2S)-pyrrolidin-2-yl]imidazo[1 and 5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide
InChI=1S/C22H21N7O/c23-20-19-18(28-21(16-4-3-11-24-16)29(19)13-12-26-20)14-6-8-15(9-7-14)22(30)27-17-5-1-2-10-25-17/h1-2,5-10,12-13,16,24H,3-4,11H2,(H2,23,26)(H,25,27,30)/t16-/m0/s1